Retaglutide is a novel GLP-1 receptor agonist currently under study for the treatment of metabolic disorders. This drug works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://janedecc575604.slypage.com/39591995/trelaglutide-exploring-a-new-therapy-for-chronic-diseases